Health and Human Services Secretary Robert F. Kennedy Jr. confirmed in a Senate Finance Committee hearing Thursday that the U.S. Food and Drug Administration is actively reviewing the drug responsible for more than half of the nation’s abortions.
“We’re getting data in all the time, new data that we’re reviewing,” Kennedy told Republican Sen. James Lankford. “And we know that during the Biden administration, they actually twisted the data to bury one of the safety signals with a very high safety signal, around 11 percent.”
Kennedy not only committed to ensuring “that that doesn’t happen anymore,” but also said “we’re producing … science and gold standard science on that.”
Kennedy affirmed in a later exchange with Montana Sen. Steve Daines that he was unsure of the type of studies FDA Commissioner Marty Makary and his agency are pursuing, but that they are “progressing” and “ongoing.”
“I know I talked to Marty Makary about it yesterday, and he said those studies are progressing and that they’re ongoing,” Kennedy said.
Kennedy disclosed during a similar hearing in May that he asked Makary to do a “complete review” of mifepristone data and “report back.” Makary has also repeatedly committed to looking at incoming information about the effects of the abortion pill on women and children and potentially “take action.”
The HHS Secretary did not give a timeline for the request but confirmed Sen. Josh Hawley’s speculation that the review will be “top priority.”
Kennedy’s pledge came on the heels of findings that suggested the rate of serious or life-threatening complications after ingesting the abortion pill is 22 times higher than the FDA label claims.
“It’s alarming, and … it indicates that at very least, the label should be changed,” Kennedy said of the study’s determination.
Another study published that same month found that 83 percent of emergency room visits due to drug-induced abortion are miscoded as “miscarriages.” As researchers noted, this misclassification, often due to deliberate concealment of a drug-induced abortion at the behest of abortion activists, could deprive women of the emergent care they need for the serious adverse events linked to mifepristone.
Abortion giants and their allies in the corporate media pretend Mifepristone is safer than Tylenol, a claim that has not only been proven baseless but one that Planned Parenthood also faces suit over.
Yet, Planned Parenthood’s promotion of the abortion pill, paired with relaxed mifepristone guidance led by the Obama and Biden administrations, has fueled a rapid rise in at-home DIY abortions.
The popularity of the abortion drug regimen has put countless babies and women in harm’s way, with side effects such as hemorrhage, “fast, weak pulse,” “trouble breathing,” diarrhea, dizziness, headache, vomiting, “pain” across the back, arms, neck, and abdomen. In some cases, the pills have led to death or hospitalization due to hemorrhaging, sepsis, or infection that can result in follow-up surgeries.
Not only are the pills dangerous, but they are enabling abuse. Nearly 70 percent of abortions are believed to be unwanted, coerced, or inconsistent with the mother’s values and desires.
As demonstrated in several recent lawsuits, women who want to keep their pregnancies have been allegedly poisoned with abortion drugs by their sexual partners. As the suits detail, the result has not only been a loss of unborn life but also physical complications in the mothers that required medical intervention.
Kennedy said during the hearing he would “get back” to Sen. Daines, who asked if the HHS will “repeal the Covid-era telemedicine allowance for chemical abortion drugs and restore the requirement for an in-person doctor visit.” He did confirm, however, that the nongovernmental organizations refusing to comply with the Trump administration’s Title 10 funding prohibition on abortion activities “are not getting funded.”